Elizabeth Mary Beck

This inventor holds 19 USPTO granted patents and 1 published patent application, plus 4 CIPO patents and 3 EPO patents, primarily in Pharmaceutical Chemistry. Top assignee: Pfizer Corporation. Active years: 2014-2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Elizabeth Mary Beck. Retrieved from https://idiyas.com/inventor/elizabeth-mary-beck

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 (Patent Applications = 1)

% Patents Active = 31.6

CIPO Patents = 4 (Patent Applications = 11)

EPO Patents = 3 (Patent Applications = 8)

Average Co-Inventor Count = 6.5

ph-index = 9

Forward Citations = 162(Granted Patents)

Location History:

Cambridge, MA (US) (2014 - 2016)
Edinburgh, GB (2016 - 2017)
Abingdon, GB (2019 - 2020)
Oxford, GB (2018 - 2021)

Company Filing History:

19 out of 4,488

Pfizer Corporation

patents

Years Active: 2014-2021

Loading Chart...

Areas of Expertise:

MAGL Inhibitors

Dihydro-Pyrrolo-Pyridine

Carbamate Derivatives

Thiazine Compounds

Hexahydropyrano

Heteroaryl

Alkyl-Substituted

Heterocyclic

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11198692 - Dihydro-pyrrolo-pyridine derivatives (2021-12-14),

2. 10723711 - 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors (2020-07-28),

3. 10604519 - 5,7-dihydro-pyrrolo-pyridine derivatives (2020-03-31),

4. 10428034 - 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors (2019-10-01),

5. 10028962 - 2-amino-6-methy1-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides (2018-07-24),

6. 9845301 - 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors (2017-12-19),

7. 9744173 - 2-amino 6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides (2017-08-29),

8. 9605007 - 2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides (2017-03-28),

9. 9428523 - 2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides (2016-08-30),

10. 9315520 - 2-amino-6-methyl-4,4a,5,6-tetrahydropyrano[3,4-d][1,3]thiazin-8a(8H)-yl-1,3-thiazol-4-yl amides (2016-04-19),

11. 9260455 - Alkyl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds (2016-02-16),

12. 9233981 - [object Object] (2016-01-12),

13. 9198917 - [object Object] (2015-12-01),

14. 9192612 - Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds (2015-11-24),

15. 9045499 - Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds (2015-06-02),

Title: Elizabeth Mary Beck - Innovator from Cambridge

Introduction: Elizabeth Mary Beck is a pioneering inventor based in Cambridge, MA, known for her groundbreaking contributions to various fields.

Latest Patents: Elizabeth Mary Beck holds several patents in the areas of biotechnology, renewable energy, and medical devices, showcasing her diverse range of expertise.

Career Highlights: With a career spanning over two decades, Elizabeth Mary Beck has worked with prestigious research institutions and universities, leading innovative projects that have resulted in significant technological advancements.

Collaborations: Throughout her career, Elizabeth Mary Beck has collaborated with top companies, patent attorneys, and fellow inventors, fostering a culture of innovation and knowledge sharing.

Conclusion: Elizabeth Mary Beck's passion for pushing the boundaries of technology and her relentless drive for innovation make her a true trailblazer in the world of inventions.

Profile summary based on public USPTO records.